A one health nanotechnology approach to address antimicrobial resistance: state-of-the-art and strategic outlook

IF 4.7 Q2 MATERIALS SCIENCE, MULTIDISCIPLINARY
Ansh Desai, Subhojit Ghosh, Subramanian Sankaranarayanan, Dhiraj Bhatia and Amit K. Yadav
{"title":"A one health nanotechnology approach to address antimicrobial resistance: state-of-the-art and strategic outlook","authors":"Ansh Desai, Subhojit Ghosh, Subramanian Sankaranarayanan, Dhiraj Bhatia and Amit K. Yadav","doi":"10.1039/D5MA00487J","DOIUrl":null,"url":null,"abstract":"<p >Antimicrobial resistance (AMR) has emerged as a critical global health threat, driven by the rapid evolution and dissemination of resistance mechanisms among pathogens, and exacerbated by the interconnectedness of human, animal, and environmental health sectors. This review provides a comprehensive synthesis of the mechanisms underlying AMR including membrane permeability modification, efflux pumps, enzymatic inactivation, and target site modification while framing the crisis within the One Health perspective that emphasizes cross-sectoral collaboration and holistic strategies. The article systematically evaluates current approaches to combating AMR, such as novel drug discovery, combination therapies, bacteriophage-based interventions, antimicrobial adjuvants, and antimicrobial peptides, highlighting their respective strengths and limitations. The core of the review focuses on the advances in nanotechnology-based strategies, detailing the antimicrobial potential of diverse nanomaterials including chitosan, poly(lactic-<em>co</em>-glycolic acid) (PLGA) nanoparticles, liposomes, solid lipid nanoparticles, metal and metal ion nanoparticles (<em>e.g</em>., zinc oxide, silver, copper, gold, titanium, magnetic, cobalt), carbon dots, dendrimers, and hydrogels. Special attention is given to their mechanisms of action, efficacy against multidrug-resistant organisms, and applicability across human, veterinary, and environmental contexts. Moreover, the review addresses the limitations of nanotechnology-based approaches, such as nanoparticle cytotoxicity, the potential for nanoparticle-induced resistance, and the toxicological and ecological risks posed to One Health ecosystems. By critically appraising these challenges, the review identifies key research gaps and regulatory hurdles that must be overcome to enable the safe and effective clinical translation of nano-antimicrobials. The article concludes by outlining future prospects for the field, advocating for interdisciplinary research, responsible stewardship, and innovative policy frameworks to sustain the fight against AMR and protect global health.</p>","PeriodicalId":18242,"journal":{"name":"Materials Advances","volume":" 19","pages":" 6612-6647"},"PeriodicalIF":4.7000,"publicationDate":"2025-08-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://pubs.rsc.org/en/content/articlepdf/2025/ma/d5ma00487j?page=search","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Materials Advances","FirstCategoryId":"1085","ListUrlMain":"https://pubs.rsc.org/en/content/articlelanding/2025/ma/d5ma00487j","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"MATERIALS SCIENCE, MULTIDISCIPLINARY","Score":null,"Total":0}
引用次数: 0

Abstract

Antimicrobial resistance (AMR) has emerged as a critical global health threat, driven by the rapid evolution and dissemination of resistance mechanisms among pathogens, and exacerbated by the interconnectedness of human, animal, and environmental health sectors. This review provides a comprehensive synthesis of the mechanisms underlying AMR including membrane permeability modification, efflux pumps, enzymatic inactivation, and target site modification while framing the crisis within the One Health perspective that emphasizes cross-sectoral collaboration and holistic strategies. The article systematically evaluates current approaches to combating AMR, such as novel drug discovery, combination therapies, bacteriophage-based interventions, antimicrobial adjuvants, and antimicrobial peptides, highlighting their respective strengths and limitations. The core of the review focuses on the advances in nanotechnology-based strategies, detailing the antimicrobial potential of diverse nanomaterials including chitosan, poly(lactic-co-glycolic acid) (PLGA) nanoparticles, liposomes, solid lipid nanoparticles, metal and metal ion nanoparticles (e.g., zinc oxide, silver, copper, gold, titanium, magnetic, cobalt), carbon dots, dendrimers, and hydrogels. Special attention is given to their mechanisms of action, efficacy against multidrug-resistant organisms, and applicability across human, veterinary, and environmental contexts. Moreover, the review addresses the limitations of nanotechnology-based approaches, such as nanoparticle cytotoxicity, the potential for nanoparticle-induced resistance, and the toxicological and ecological risks posed to One Health ecosystems. By critically appraising these challenges, the review identifies key research gaps and regulatory hurdles that must be overcome to enable the safe and effective clinical translation of nano-antimicrobials. The article concludes by outlining future prospects for the field, advocating for interdisciplinary research, responsible stewardship, and innovative policy frameworks to sustain the fight against AMR and protect global health.

Abstract Image

解决抗菌素耐药性的单一卫生纳米技术方法:最新技术和战略展望
抗菌素耐药性(AMR)已成为严重的全球健康威胁,其驱动因素是病原体间耐药性机制的迅速演变和传播,并因人类、动物和环境卫生部门的相互联系而加剧。这篇综述全面综合了AMR的机制,包括膜渗透性修饰、外排泵、酶失活和靶点修饰,同时在强调跨部门合作和整体战略的“同一个健康”视角下构建危机。本文系统地评估了目前对抗抗菌素耐药性的方法,如新药发现、联合疗法、基于噬菌体的干预、抗菌辅助剂和抗菌肽,并强调了它们各自的优势和局限性。综述的核心是基于纳米技术的策略的进展,详细介绍了各种纳米材料的抗菌潜力,包括壳聚糖、聚乳酸-羟基乙酸(PLGA)纳米颗粒、脂质体、固体脂质纳米颗粒、金属和金属离子纳米颗粒(如氧化锌、银、铜、金、钛、磁性、钴)、碳点、树状大分子和水凝胶。特别关注它们的作用机制,对多药耐药生物的功效,以及在人类、兽医和环境背景下的适用性。此外,该综述还讨论了基于纳米技术的方法的局限性,例如纳米颗粒细胞毒性、纳米颗粒诱导耐药性的可能性以及对One Health生态系统构成的毒理学和生态风险。通过批判性地评估这些挑战,本综述确定了必须克服的关键研究差距和监管障碍,以实现安全有效的纳米抗菌素临床转化。文章最后概述了该领域的未来前景,倡导跨学科研究、负责任的管理和创新的政策框架,以维持与抗生素耐药性的斗争并保护全球健康。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Materials Advances
Materials Advances MATERIALS SCIENCE, MULTIDISCIPLINARY-
CiteScore
7.60
自引率
2.00%
发文量
665
审稿时长
5 weeks
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信